In BRCA, HMGA1 demonstrated prominent expression across multiple T lymphocyte populations, including CD4+ conventional T cells, CD8+ T cells, and regulatory T cells (Treg) (Supplementary Figure S8A). This evidence concerns the gene CD8A and invasive breast carcinoma.